Cargando…

Efzofitimod for the Treatment of Pulmonary Sarcoidosis

BACKGROUND: Pulmonary sarcoidosis is characterized by the accumulation of immune cells that form granulomas affecting the lungs. Efzofitimod (ATYR1923), a novel immunomodulator, selectively binds neuropilin 2, which is upregulated on immune cells in response to lung inflammation. RESEARCH QUESTION:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Culver, Daniel A., Aryal, Shambhu, Barney, Joseph, Hsia, Connie C.W., James, W. Ennis, Maier, Lisa A., Marts, Lucian T., Obi, Ogugua Ndili, Sporn, Peter H.S., Sweiss, Nadera J., Shukla, Sanjay, Kinnersley, Nelson, Walker, Gennyne, Baughman, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians 2023
Materias:	Diffuse Lung Disease: Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258437/ https://www.ncbi.nlm.nih.gov/pubmed/36356657 http://dx.doi.org/10.1016/j.chest.2022.10.037

Ejemplares similares

Exposure-response analyses of efzofitimod in patients with pulmonary sarcoidosis
por: Walker, Gennyne, et al.
Publicado: (2023)

Efzofitimod: a novel anti-inflammatory agent for sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2023)

Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017)

Phase II Investigation of the Efficacy of Antimycobacterial Therapy in Chronic Pulmonary Sarcoidosis
por: Drake, Wonder P., et al.
Publicado: (2021)

OUTCOMES IN PATIENTS WITH SARCOIDOSIS DIAGNOSED WITH COVID-19
por: NADEEM, OWAIS, et al.
Publicado: (2021)

MULTISYSTEM SARCOIDOSIS ASSOCIATED WITH THE COVID-19 MRNA VACCINE
por: MITMA, ANGEL A, et al.
Publicado: (2022)

Pulmonary Sarcoidosis: Beyond Restriction and Forced Vital Capacity
por: Obi, Ogugua Ndili
Publicado: (2023)

Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches
por: Obi, Ogugua Ndili, et al.
Publicado: (2022)

Sarcoidosis: An Occupational Disease?
por: Oliver, L. Christine, et al.
Publicado: (2021)

High-Definition Videobronchoscopy for the Diagnosis of Airway Involvement in Sarcoidosis: The Enhance Sarcoidosis Multicenter Study
por: Livi, Vanina, et al.
Publicado: (2023)

Diagnostic Performance of Electronic Nose Technology in Sarcoidosis
por: van der Sar, Iris G., et al.
Publicado: (2022)

ELECTRONIC VAPE-ASSOCIATED LUNG INJURY: A UNIQUE PRESENTATION
por: Hawk, Fahad, et al.
Publicado: (2020)

FIBROTIC PROTEASE 3 ANCA-ASSOCIATED VASCULITIS
por: Megri, Mohammed, et al.
Publicado: (2020)

CHILDHOOD-ONSET INTERSTITIAL LUNG DISEASE: A RARE CASE OF IDIOPATHIC, NONSPECIFIC INTERSTITIAL PNEUMONIA IN A TEENAGER
por: Cerro, Giuliana, et al.
Publicado: (2020)

AN UNUSUAL PRESENTATION OF NONSPECIFIC INTERSTITIAL PNEUMONIA
por: Matta, Atul, et al.
Publicado: (2020)

NOT ALL ARDS IS COVID: THE RISK OF PREMATURE CLOSURE AND THE VALUE OF MULTIDISCIPLINARY DISCUSSION
por: VARGAS, JORGE, et al.
Publicado: (2021)

THE PERFECT STORM: DIFFUSE ALVEOLAR HEMORRHAGE AFTER SARS-COV-2 INFECTION
por: WANG, EDWARD, et al.
Publicado: (2021)

THINKING BEYOND COVID-19: A CASE OF KRATOM-INDUCED PNEUMONITIS
por: MINICH, CORBYN, et al.
Publicado: (2021)

PULMONARY ALVEOLAR PROTEINOSIS SUBMITTED A WHOLE LUNG LAVAGE AFTER COVID-19: A CASE REPORT
por: D'AMBROSIO, PAULA, et al.
Publicado: (2021)

COVID-19 VACCINE UPTAKE IN AN INTERSTITIAL LUNG DISEASE CLINIC
por: LEAHY, AMY, et al.
Publicado: (2021)

A CASE OF STEROID RESPONSIVE SEVERE PNEUMONIA RELATED TO IMMUNE-LIKE RECONSTITUTION INFLAMMATORY RESPONSE 3 MONTHS AFTER RITUXIMAB THERAPY FOR PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCAL INFECTIONS
por: POURSHAHID, SEYEDMOHAMMAD, et al.
Publicado: (2021)

A CASE OF SEVERE HYPOXEMIA AND HEMOPTYSIS SECONDARY TO E-CIGARETTE AND VAPING PRODUCT USE-ASSOCIATED LUNG INJURY IN COVID-19 ERA
por: POLISETTY, LAKSHMI, et al.
Publicado: (2021)

ORGANIZING PNEUMONIA FOLLOWING COVID-19: A REPORT OF 8 CASES
por: BETHLEM, MARCOS, et al.
Publicado: (2021)

A CASE OF SEVERE E-CIGARETTE OR VAPING PRODUCT USE-ASSOCIATED LUNG INJURY IN THE TIME OF COVID-19
por: WASSERMAN, EVAN, et al.
Publicado: (2021)

MORTALITY AND ITS PREDICTORS IN PATIENTS WITH COVID-19 WITH PREEXISTING INTERSTITIAL LUNG DISEASE
por: DUTT, N., et al.
Publicado: (2022)

AGGRESSIVE AND RAPID NASCENT HONEY COMBING DURING ACUTE COVID-19 INFECTION: A CASE REPORT
por: JOSHI, V., et al.
Publicado: (2022)

A CASE REPORT OF COMPLICATIONS IN A SURVIVOR OF SEVERE COVID-19: PULMONARY FIBROSIS AND LONG-TERM SUPPLEMENTAL OXYGEN REQUIREMENT
por: YANAMADALA, A.
Publicado: (2022)

EXTENSION OF STEROID THERAPY FOR POST-COVID-19 FIBROTIC LUNG SEQUALAE
por: TOUMAN, A., et al.
Publicado: (2022)

ORGANIZING PNEUMONIA AS A SIDE EFFECT OF COVID-19 VACCINE
por: DADHWAL, R., et al.
Publicado: (2022)

PREDICTORS OF POST-COVID-19 PULMONARY FIBROSIS: A CASE SERIES
por: CÎRJALIU, R.-E., et al.
Publicado: (2022)

DERMATOMYOSITIS AFTER COVID-19 PNEUMONIA
por: KHANAM, VERISHA, et al.
Publicado: (2022)

WITHDRAWN
Publicado: (2022)

PUTTING THE "SARS” IN "SARS-COVID-19": A CASE OF SARCOID-LIKE INFLAMMATORY REACTION AFTER COVID-19 VACCINATION
por: JAFRI, MUSTAFA HUS, et al.
Publicado: (2022)

COVID-19 PNEUMONIA AND PERICARDITIS IN A PATIENT WITH UNTREATED CYSTIC LUNG DISEASE
por: KOZLIK, ANN, et al.
Publicado: (2022)

COVID-19 VACCINE-RELATED PNEUMONITIS
por: TSENG, CHENGTIN, et al.
Publicado: (2022)

Lung Transplantation for Patients With COVID-19
por: King, Christopher S., et al.
Publicado: (2022)

COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities
por: Manansala, Michael, et al.
Publicado: (2021)

First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative
por: Kampstra, Nynke A, et al.
Publicado: (2019)

Editorial: Sarcoidosis—The great mimicker
por: Korsten, Peter, et al.
Publicado: (2022)

Activity tracking devices in sarcoidosis
por: Klein, Rebecca A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mvs7ompkebrj050d0vtdv9rrbk